, Amoxicillin was effective in inhibiting planktonic bacterial growth at low concentrations and all the bacteria would be considered susceptible based upon EUCAST breakpoints

, Bacterial biofilms were readily formed by E. faecalis, most of Streptococcus, C. acnes and E. coli on the CBD, vol.4, p.10

, Regarding Streptococcus gender, 2/4 S. dysgalactiae strains were not able to form biofilm under our experimental conditions (< 5000 CFU/pegs)

, Two S. dysgalactiae MBEC ranged from 0.031 to 0.062 mg/L, which is comparable to their MIC (0.023 to 0.032 mg/L). Duplicates are being run to determine the missing Streptococcus MBEC. MBEC measured for C. acnes ranged from 0, Amoxicillin was effective in killing biofilm bacteria at relatively low concentrations for 3 Streptococcus and Cutibacterium acnes

, For the E. coli, MBEC was equal to the MIC whereas in literature E. coli ATCC 25922 MBEC is described to be a hundred times higher than the MIC (48). Our results for ATCC E, contrast, E. faecalis MBEC ranged from 64 to 128 mg/L, which is 100 times higher than the MICs (ranging from 0.38 to 1 mg/L)

, Regarding BPC, concentrations ranged from 0.5 to 1 mg/L for E. faecalis. These values are comparable to MIC (0.38 to 1 mg/L). For C. acnes, BPC are very high ranging from 2 to 256 mg/L. Moreover, a biofilm induction

C. Dye, After 2015: infectious diseases in a new era of health and development, Philos Trans R

. Soc-b-biol and . Sci, Disponible sur, vol.369, 1645.

G. Habib, P. Lancellotti, M. J. Antunes, M. G. Bongiorni, J. Casalta et al., ESC Guidelines for the management of infective endocarditisThe Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM), Eur Heart J, vol.36, issue.44, pp.3075-128, 2015.

, Clinical Guidelines for the Antimicrobial Treatment of Bone and Joint Infections in Korea. Infect Chemother. juin, vol.46, issue.2, pp.125-163, 2014.

J. Saavedra-lozano, O. Falup-pecurariu, S. N. Faust, H. Girschick, N. Hartwig et al.,

, Bone and Joint Infections. Pediatr Infect Dis J. août, vol.36, issue.8, pp.788-99, 2017.

D. A. Spyker, R. J. Rugloski, R. L. Vann, O. &apos;brien, and W. M. , Pharmacokinetics of Amoxicillin: Dose Dependence After Intravenous, Oral, and Intramuscular Administration, Antimicrob Agents Chemother. janv, vol.11, issue.1, pp.132-173, 1977.

J. Raposo, R. Teotónio, C. Bento, and F. Sales, Amoxicillin, a potential epileptogenic drug, Epileptic Disord. 1 déc, vol.18, issue.4, pp.454-461, 2016.

J. Cundiff and S. Joe, Amoxicillin-clavulanic acid-induced hepatitis, Am J Otolaryngol. 1 janv, vol.28, issue.1, pp.28-30, 2007.

R. Mrvos, T. L. Pummer, and E. P. Krenzelok, Amoxicillin Renal Toxicity: How Often Does It Occur?

, Pediatr Emerg Care. mai, vol.29, issue.5, p.641, 2013.

. Netgen, Suivi thérapeutique des médicaments (II) la pratique clinique1. Rev Médicale Suisse

D. Sur,

, Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review, STP & personnalisation des traitements, vol.14, p.140, 2014.

S. Chetty and A. S. Mitha, High-dose oral amoxycillin in the treatment of infective endocarditis

, South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 18 juin, vol.73, issue.12, pp.709-719, 1988.

D. Stamboulian, P. Bonvehi, C. Arevalo, R. Bologna, I. Cassetti et al., Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci, Rev Infect Dis. févr, vol.13, issue.2, pp.160-163, 1991.

G. Walter, M. Vernier, P. O. Pinelli, M. Million, M. Coulange et al., Bone and joint infections due to anaerobic bacteria: an analysis of 61 cases and review of the literature, Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. août, vol.33, issue.8, pp.1355-64, 2014.

P. Seng, M. Vernier, A. Gay, P. Pinelli, R. Legré et al., Clinical features and outcome of bone and joint infections with streptococcal involvement: 5-year experience of interregional reference centres in the south of France, New Microbes New Infect. 13 avr, vol.12, pp.8-17, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01771124

N. Høiby, T. Bjarnsholt, C. Moser, G. L. Bassi, T. Coenye et al., ESCMID * guideline for the diagnosis and treatment of biofilm infections, Clin Microbiol Infect. 1 mai, vol.21, pp.1-25, 2014.

M. H. Abdul-aziz, J. Lipman, J. W. Mouton, W. W. Hope, and J. A. Roberts, Applying

, pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development, Semin Respir Crit Care Med. févr, vol.36, issue.1, pp.136-53, 2015.

F. Jehl and D. Levêque, Perfusion continue des bêtalactamines : intérêts, inconvénients, modalités pratiques, 2009.

E. Dailly, M. Verdier, G. Deslandes, R. Bouquié, O. Tribut et al.,

, Therapie. avr, vol.67, issue.2, pp.145-154, 2012.

W. L. Chai, H. Hamimah, S. C. Cheng, A. A. Sallam, and M. Abdullah, Susceptibility of Enterococcus faecalis biofilm to antibiotics and calcium hydroxide, J Oral Sci. juin, vol.49, issue.2, pp.161-167, 2007.

C. Ruppen, A. Hemphill, and P. Sendi, In vitro activity of gentamicin as an adjunct to penicillin against biofilm group B Streptococcus, J Antimicrob Chemother. 1 févr, vol.72, issue.2, pp.444-451, 2017.

C. Jacqueline and J. Caillon, Impact of bacterial biofilm on the treatment of prosthetic joint infections, J Antimicrob Chemother. 1 sept, vol.69, issue.suppl_1, pp.37-40, 2014.

M. J. Sedlacek and C. Walker, Antibiotic resistance in an in vitro subgingival biofilm model, Oral Microbiol Immunol. oct, vol.22, issue.5, pp.333-342, 2007.

D. D. Bo?i?, B. Pavlovi?, J. Milovanovi?, A. Joti?, J. ?olovi? et al., Antibiofilm effects of amoxicillin-clavulanic acid and levofloxacin in patients with chronic rhinosinusitis with nasal polyposis, Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol -Head Neck Surg. août, vol.275, issue.8, pp.2051-2060, 2018.

A. A. Ferran, J. Liu, P. Toutain, and A. Bousquet-mélou, Comparison of the In vitro Activity of

M. J. González, L. Robino, V. Iribarnegaray, P. Zunino, and P. Scavone, Five Antimicrobial Drugs against Staphylococcus pseudintermedius and Staphylococcus aureus Biofilms. Front Microbiol, vol.2

, Recommandations de bonnes pratiques Prothèse de hanche ou de genou : diagnostic et prise en charge de l'infection dans le mois suivant l'implantation, HAS, 2014.

D. Sur,

T. J. Cahill and B. D. Prendergast, Infective endocarditis, Lancet Lond Engl. 27 févr, vol.387, pp.882-93, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01489511

, Collège des universitaires des Maladies Infectieuses et Tropicales. ECN.PILLY, p.6, 2018.

F. Thuny, D. Grisoli, F. Collart, G. Habib, and D. Raoult, Management of infective endocarditis: challenges and perspectives, The Lancet. mars, vol.379, issue.9819, pp.965-75, 2012.

D. R. Murdoch, G. R. Corey, B. Hoen, J. M. Miró, V. G. Fowler et al.,

, Etiology and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis-Prospective Cohort Study, Arch Intern Med. 9 mars, vol.169, issue.5, pp.463-73, 2009.

S. Malekzadeh-milani, A. Houeijeh, Z. Jalal, S. Hascoet, M. Bakloul et al., French national survey on infective endocarditis and the Melody TM valve in percutaneous pulmonary valve implantation, Arch Cardiovasc Dis. 1 août, vol.111, issue.8, pp.497-506, 2018.

C. Selton-suty, M. Célard, L. Moing, V. Doco-lecompte, T. Chirouze et al.,

, Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey

, Clin Infect Dis Off Publ Infect Dis Soc Am. mai, vol.54, issue.9, pp.1230-1239, 2012.

. Société-française-de-microbiologie and . Endocardite,

. Microbiologie, , pp.139-183, 2015.

, Collège des universitaires des Maladies Infectieuses et Tropicales. ECN.PILLY, 2018.

, Infections ostéo-articulaires (IOA) de l'adulte et de l'enfant [Internet]. 5ème édition

, García-Arias M, Balsa A, Mola EM. Septic arthritis, Best Pract Res Clin Rheumatol. juin, vol.25, issue.3, pp.407-428, 2011.

J. Colston and B. Atkins, Bone and joint infection, Clin Med. 4 janv, vol.18, issue.2, pp.150-154, 2018.

. Société-française-de-microbiologie, Infections osseuses et articulaires, REMIC : Société Française de Microbiologie, pp.285-94, 2015.

D. R. Osmon, E. F. Berbari, A. R. Berendt, D. Lew, W. Zimmerli et al., Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America, Clin Infect Dis. 1 janv, vol.56, issue.1, pp.1-25, 2013.

. Idibell-b and P. Navarra, Clinical practice guidelines by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

A. Voie-injectable-:-gentamicine, . Tobramycine, and A. Nétilmicine,

D. Sur,

D. Lebeaux, A. Chauhan, O. Rendueles, and C. Beloin, From in vitro to in vivo Models of Bacterial Biofilm-Related Infections, Pathogens. 13 mai, vol.2, issue.2, pp.288-356, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-01385428

Y. Tremblay, S. Hathroubi, and M. Jacques, Les biofilms bactériens : leur importance en santé animale et en santé publique, Can J Vet Res. avr, vol.78, issue.2, pp.110-116, 2014.

M. E. Olson, I. Ruseska, and J. W. Costerton, Colonization ofn-butyl-2-cyanoacrylate tissue adhesive byStaphylococcus epidermidis, J Biomed Mater Res. juin, vol.22, issue.6, pp.485-95, 1988.

J. W. Costerton, P. S. Stewart, and E. P. Greenberg, Bacterial Biofilms: A Common Cause of Persistent Infections, Sci New Ser, vol.284, issue.5418, pp.1318-1340, 1999.

M. D. Macia, E. Rojo-molinero, and A. Oliver, Antimicrobial susceptibility testing in biofilmgrowing bacteria, Clin Microbiol Infect, vol.20, issue.10, pp.981-90, 2014.

H. Ceri, M. E. Olson, C. Stremick, R. R. Read, D. Morck et al.,

, New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms, J Clin Microbiol. 6 janv, vol.37, issue.6, pp.1771-1777, 1999.

H. Ceri, M. Olson, D. Morck, D. Storey, R. Read et al.,

, Multiple equivalent biofilms for antibiotic and biocide susceptibility testing, Doyle RJ, éditeur. Methods in Enzymology, vol.337, pp.377-85, 2001.

D. Sur,

D. Rodrigues, N. Cerca, P. Teixeira, R. Oliveira, H. Ceri et al., Listeria monocytogenes and Salmonella enterica Enteritidis Biofilms Susceptibility to Different Disinfectants and Stress-Response and Virulence Gene Expression of Surviving Cells, Int J Antimicrob Agents. août, vol.17, issue.2, pp.173-179, 2011.

G. Soares, F. Teles, J. R. Starr, M. Feres, M. Patel et al., Effects of azithromycin, metronidazole, amoxicillin, and metronidazole plus amoxicillin on an in vitro polymicrobial subgingival biofilm model, Antimicrob Agents Chemother. mai, vol.59, issue.5, pp.2791-2799, 2015.

M. Zaborowska, J. Tillander, R. Brånemark, L. Hagberg, P. Thomsen et al., Biofilm formation and antimicrobial susceptibility of staphylococci and enterococci from osteomyelitis associated with percutaneous orthopaedic implants: BIOFILM FORMATION AND ANTIMICROBIAL SUSCEPTIBILITY, J Biomed Mater Res B Appl Biomater, vol.105, issue.8, pp.2630-2670, 2017.

J. Sandoe, J. Wysome, A. P. West, J. Heritage, and M. H. Wilcox, Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms, J Antimicrob Chemother. avr, vol.57, issue.4, pp.767-70, 2006.

J. B. Kaplan, Antibiotic-induced biofilm formation, Int J Artif Organs. sept, vol.34, issue.9, pp.737-51, 2011.

J. B. Kaplan, E. A. Izano, P. Gopal, M. T. Karwacki, S. Kim et al., Low Levels of ?-Lactam Antibiotics Induce Extracellular DNA Release and Biofilm Formation in Staphylococcus aureus, pp.31-2012

K. D. Mlynek, M. T. Callahan, A. V. Shimkevitch, J. T. Farmer, J. L. Endres et al., Oxytetracycline Commonly Used to Treat Swine Increase Streptococcus suis Biofilm Formation. Front Microbiol, vol.9, 2018.

, Effects of Low-Dose Amoxicillin on Staphylococcus aureus USA300 Biofilms, Antimicrob Agents Chemother. 22 avr, vol.60, issue.5, pp.2639-51, 2016.

N. A. Ahmed, F. C. Petersen, and A. A. Scheie, AI-2/LuxS Is Involved in Increased Biofilm Formation by Streptococcus intermedius in the Presence of Antibiotics, Antimicrob Agents Chemother, vol.53, issue.10, pp.4258-63, 2009.

F. De-velde, B. De-winter, B. Koch, T. Van-gelder, and J. W. Mouton, COMBACTE-NET consortium. Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints, J Antimicrob Chemother, vol.71, issue.10, pp.2909-2926, 2016.

C. Economou, G. Wong, B. Mcwhinney, J. Ungerer, J. Lipman et al., Impact of ?-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy, Int J Antimicrob Agents. 1 mai, vol.49, issue.5, pp.589-94, 2017.

M. Carlier, V. Stove, S. C. Wallis, J. J. De-waele, A. G. Verstraete et al., Assays for therapeutic drug monitoring of ?-lactam antibiotics: A structured review, Int J Antimicrob Agents, vol.46, issue.4, pp.367-75, 2015.

M. Osthoff, M. Siegemund, G. Balestra, M. H. Abdul-aziz, and J. A. Roberts, Prolonged administration of ?-lactam antibiotics -a comprehensive review and critical appraisal, Swiss Med Wkly, vol.146, p.14368, 2016.

T. Larsen and N. Fiehn, Resistance of Streptococcus sanguis biofilms to antimicrobial agents

, APMIS. 1 janv, vol.104, issue.1-6, pp.280-284, 1996.

A. Lepape, Y a-t-il des spécificités dans la prise en charge des infections liées aux cathéters suivant la microbiologie ?, Ann Fr Anesth Réanimation. 1 mars, vol.24, issue.3, pp.298-301, 2005.

H. Flemming, J. Wingender, U. Szewzyk, P. Steinberg, S. A. Rice et al., Biofilms: an emergent form of bacterial life, Nat Rev Microbiol. sept, vol.14, issue.9, pp.563-75, 2016.

M. E. Olson, H. Ceri, D. W. Morck, A. G. Buret, and R. R. Read, Biofilm bacteria: formation and comparative susceptibility to antibiotics, Can J Vet Res. avr, vol.66, issue.2, pp.86-92, 2002.

A. E. Parker, D. K. Walker, D. M. Goeres, N. Allan, M. E. Olson et al., Ruggedness and reproducibility of the MBEC biofilm disinfectant efficacy test, J Microbiol Methods. juill, vol.102, pp.55-64, 2014.

K. L. Tomlin, R. J. Malott, G. Ramage, D. G. Storey, P. A. Sokol et al., Quorum-Sensing Mutations

, Affect Attachment and Stability of Burkholderia cenocepacia Biofilms, Appl Environ Microbiol. sept, vol.71, issue.9, pp.5208-5226, 2005.

G. Soares, F. Teles, J. R. Starr, M. Feres, M. Patel et al., Effects of Azithromycin

. Metronidazole, Amoxicillin, and Metronidazole plus Amoxicillin on an In Vitro Polymicrobial Subgingival Biofilm Model, vol.59, pp.2791-2799, 2015.

U. S. , Department of Health and Human Services Food and Drug Administration

, Industry Bioanalytical Method Validation Guidance for Industry Bioanalytical Method Validation, Vet Med, 2001.

T. M. Annesley, Ion suppression in mass spectrometry, Clin Chem. juill, vol.49, issue.7, pp.1041-1045, 2003.

J. Bland and D. , Comparing methods of measurement: why plotting difference against standard method is misleading, Lancet, vol.346, pp.1085-1092, 1995.

J. J. Harrison, R. J. Turner, and H. Ceri, High-throughput metal susceptibility testing of microbial biofilms, BMC Microbiol, vol.5, 2005.

S. Disponible-sur-;-stepanovi?, I. ?irkovi?, L. Ranin, and M. S?vabi?-vlahovi?, Biofilm formation by Salmonella spp. and Listeria monocytogenes on plastic surface, Lett Appl Microbiol. 1 mai, vol.38, issue.5, pp.428-460, 2004.

S. Revdiwala, B. M. Rajdev, S. Mulla, A. J. Brady, G. Laverty et al., Antibiotic susceptibility of planktonic-and biofilm-grown staphylococci isolated from implant-associated infections: should MBEC and nature of biofilm formation replace MIC?, Crit Care Res Pract, vol.66, issue.4, pp.461-470, 2012.

J. Pullen, L. Stolk, F. Nieman, P. Degraeuwe, F. H. Van-tiel et al.,

, Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates, Ther Drug Monit. avr, vol.28, issue.2, pp.226-257, 2006.

D. Adam, I. Visser, and P. Koeppe, Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination, Antimicrob Agents Chemother. sept, vol.22, issue.3, pp.353-360, 1982.

M. H. Abdul-aziz, H. Sulaiman, M. Mat-nor, V. Rai, K. K. Wong et al.,

, Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis, Intensive Care Med, vol.42, issue.10, pp.1535-1580, 2016.

M. H. Abdul-aziz, J. M. Dulhunty, R. Bellomo, J. Lipman, and J. A. Roberts, Continuous beta-lactam infusion in critically ill patients: the clinical evidence. Ann Intensive Care, 16 août, vol.2, issue.1, p.37, 2012.

J. A. Roberts, A. Davis, J. S. Dulhunty, J. M. Cotta, M. O. Myburgh et al.,

, Continuous versus Intermittent ?-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials, Am J Respir Crit Care Med, vol.15, issue.6, pp.681-91, 2016.

J. H. Jorgensen and M. J. Ferraro, Antimicrobial susceptibility testing: a review of general principles and contemporary practices, Clin Infect Dis Off Publ Infect Dis Soc Am. 1 déc, vol.49, issue.11, pp.1749-55, 2009.

D. Tandé and B. Picard, Evaluation of the E-test for routine testing of the susceptibility of

, Streptococcus pneumoniae to benzylpenicillin, amoxicillin and cefotaxime, Clin Microbiol Infect. 1 août, vol.3, issue.4, pp.474-483, 1997.

G. Potel, J. Caillon, J. C. Navas, D. Kergueris, M. Batard et al., Dosage des antibiotiques en réanimation : quand et comment demander et interpréter les tests ? Réanimation, juin, vol.15, issue.1, pp.187-92, 2006.

G. Borriello, E. Werner, F. Roe, A. M. Kim, G. D. Ehrlich et al., Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms, Antimicrob Agents Chemother. juill, vol.48, issue.7, pp.2659-64, 2004.

J. B. Kaplan, Antibiotic-induced biofilm formation, Int J Artif Organs. sept, vol.34, issue.9, pp.737-51, 2011.

W. Yu, K. M. Hallinen, and K. B. Wood, Interplay between Antibiotic Efficacy and Drug-Induced

A. Messika-zeitoun, D. Eltchaninoff, H. Kapadia, S. Lerakis, S. Cheema et al., Disponible sur, Lysis Underlies Enhanced Biofilm Formation at Subinhibitory Drug Concentrations. Antimicrob Agents Chemother, vol.21

, Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry, Circulation. 5 mai, vol.131, issue.18, pp.1566-74, 2015.

A. J. Tande and R. Patel, Prosthetic Joint Infection, Clin Microbiol Rev. avr, vol.27, issue.2, pp.302-347, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01255868

M. D. Macià, E. Rojo-molinero, and A. Oliver, Antimicrobial susceptibility testing in biofilmgrowing bacteria, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.20, issue.10, pp.981-90, 2014.